ACC Late-Breakers -1-
Session Title:i2.Late Breaking Clinical Trials I
Session Type:i2.Plenary
Session Start/End Time:Saturday, Mar 28, 2009, 8:30 AM -10:00 AM
Location:Orange County Convention Center, Valencia Ballroom W415
Presentations:
Randomized Prospective Trial of Percutaneous Left Atrial Appendage Closure versus Warfarin for Stroke Prevention in Atrial Fibrillation (PROTECT AF)
Saturday, Mar 28, 2009, 8:30 AM - 8:42 AM
David R. Holmes, Jr., Vivek Reddy, Zoltan Turi, Shephal Doshi, Christopher M. Mullin, Horst Sievert, Peter Sick, Mayo Clinic, Rochester, MN
U.S. Based Economic Evaluation of PCI with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results from the SYNTAX Trial
Saturday, Mar 28, 2009, 8:50 AM - 9:02 AM
David J. Cohen, Tara A. Lavelle, Patrick W. Serruys, Friedrich W. Mohr, Haiyan Li, Kaijun Wang, Yang Lei, Kate Robertus, Elizabeth M. Mahoney, Keith D. Dawkins, A. Pieter Kappetein, SYNTAX Trial Investigators, Saint Luke's Mid America Heart Institute, Kansas City, MO, University of Missouri-Kansas City, Kansas City, MO
Comparison of Sirolimus- and Paclitaxel-Eluting Stents vs Zotarolimus-Eluting Stents in Real World Practice: The ZEST Randomized Controlled Trial
Saturday, Mar 28, 2009, 9:10 AM - 9:22 AM
Seung-Jung Park, Duk-Woo Park, Young-Hak Kim, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Yangsoo Jang, Ki Bae Seung, Hyo-Soo Kim, Seung-Jae Tahk, Myung Ho Jeong, In-Ho Chae, In-Whan Seong, Joo-Young Yang, Seung-Ho Hur, Jae-Ki Ko, Sang-Sig Cheong, Sang-Gon Lee, Nae-Hee Lee, Young-Jin Choi, Kee-Sik Kim, Taeg Jong Hong, Hun Sik Park, Junghan Yoon, Do-Sun Lim, Asan Medical Center, Seoul, South Korea
Outcomes Following Coronary Stenting in a Linked NCDR and CMS Database: A National Study of Long Term, Real-World Outcomes of Bare-Metal and Drug-Eluting Stents
Saturday, Mar 28, 2009, 9:30 AM - 9:42 AM
Pamela S. Douglas, J Matthew Brennan, Kevin Anstrom, Eric L. Eisenstein, David Dai, Ghazala Haque, David F. Kong, Ralph G. Brindis, Art Sedrakyan, David Matcher, Eric D. Peterson, Duke Clinical Research Institute, Durham, NC, MD
Session Title:i2.Late Breaking Clinical Trials II
Session Type:i2.Plenary
Session Start/End Time:Sunday, Mar 29, 2009, 8:00 AM - 9:30 AM
Location:Orange County Convention Center, Valencia Ballroom W415
Presentations:
A Randomized Comparison of Genous Stent Versus Chromium-Cobalt stent for Treatment of ST-Elevation Myocardial Infarction. A 6-month clinical, angiographic and IVUS follow-up. GENIUS-STEMI trial.
Sunday, Mar 29, 2009, 8:00 AM - 8:12 AM
Pavel Cervinka, Marian Bystron, Radim Spacek, Martin Kvasnak, Jozef Jakabcin, Department of Cardiology, Masaryk hospital, Usti nad Labem, Czech Republic
Predictors of Stent Thrombosis After Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial
Sunday, Mar 29, 2009, 8:20 AM - 8:32 AM
George D. Dangas, Alexandra J. Lansky, Bruce R. Brodie, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Dariusz Dudek, Martin Moeckel, Helen Parise, Roxana Mehran, Gregg W. Stone, Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY
Comparison of the Pre-hospital or Cath-lab Administration of High Dose Tirofiban in Patients Undergoing Primary Angioplasty. The AGIR-2 Study.
Sunday, Mar 29, 2009, 8:40 AM - 8:52 AM
Eric Bonnefoy, Carlos ElKhoury, Alvine Bissery, Pierre-Yves Dubien, Loic Belle, Guilaume Debatty, Olivier Capel, Thibaud Perret, Dominique Savary, Patrice Serre, for the AGIR-2 investigators, Hospices Civils de Lyon, Lyon, France, Université Lyon I, Lyon, France
Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One Year Outcome of ON-TIME-2.
Sunday, Mar 29, 2009, 9:00 AM - 9:12 AM
Christian W. Hamm, Arnoud W. van´t Hof, Thorsten Dill, Jurrien ten Berg, On-TIME 2 Investigators, Kerckhoff Heart Center, Bad Nauheim, Germany, Isala Klinieken, Zwolle, The Netherlands
Session Title:Late-Breaking Clinical Trials I: Congestive Heart Failure
Session Type:ACC.Special Sessions
Session Start/End Time:Sunday, Mar 29, 2009, 10:30 AM -12:00 PM
Location:Orange County Convention Center, Hall A2
CME/CE Hours:1.5
Presentations:
402-6: Surgical Treatment for Ischemic Heart Failure (STICH) Trial: CABG versus CABG + SVR
Sunday, Mar 29, 2009, 10:30 AM -10:42 AM
Robert H. Jones, STICH Hypothesis 2 Investigators, Duke Clinical Research Institute, Durham, NC, Duke University Medical Center
402-8: Multicenter Randomized Controlled Trial of Cardiac Contractility Modulation in Patients with Advanced Heart Failure
Sunday, Mar 29, 2009, 10:47 AM -10:59 AM
William T. Abraham, Alan Kadish, FIX-HF-5 Investigators, Ohio State University, Columbus, OH, Northwestern University, Chicago, IL
402-10: A Dose-Response Analysis of Patients with Heart Failure Enrolled in a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)
Sunday, Mar 29, 2009, 11:04 AM -11:16 AM
Steven J. Keteyian, Nancy Houston-Miller, Eric S. Leifer, Christopher M. O'Conner, David J. Whellan, Lawton S. Cooper, Kerry L. Lee, Stephen J. Ellis, William E. Kraus, Jerome L. Fleg, Dalane W. Kitzman, James A. Blumenthal, David S. Rendall, Debra Isaac, Alain Cohen-Solal, Ileana L. Pina, HF-ACTION Investigators, Henry Ford Hospital, Detroit, MI, Duke Clinical Research Institute, Raleigh, NC
402-12: Relaxin, A Novel Treatment for Acute Heart Failure - The Results of the Pre-RELAX-AHF Study
Sunday, Mar 29, 2009, 11:21 AM -11:33 AM
John R. Teerlink, Marco Metra, G. Michael Felker, Adriaan A. Voors, Piotr Ponikowski, Beth Weatherley, Elaine Unemori, Sam L. Teichman, Gad Cotter, Veterans Affairs Medical Center, University of California, San Francisco, CA, Department of Experimental And Applied Medicine, University of Brescia, Brescia, Italy
402-14: Can Pro-Brain Natriuretic Peptide Guided Therapy of Heart Failure Improve Heart Failure Morbidity and Mortality? Main Outcome of the PRIMA-Study
Sunday, Mar 29, 2009, 11:38 AM -11:50 AM
Luc Eurlings, Sandra van Wijk, Aggie Balk, Petra van Pol, Nicolaas de Jonge, Wouter Kok, Dave van Kraaij, Cara Lodewijks, Dirk Lok, Joan Meeder, Martin Prins, Marja van Dieijen, Robert Dennert, Harry Crijns, Yigal Pinto, University Hospital Maastricht, Maastricht, The Netherlands
Session Title:Late-Breaking Clinical Trials II: Atherosclerosis, Imaging and Other Topics
Session Type:ACC.Special Sessions
Session Start/End Time:Sunday, Mar 29, 2009, 2:00 PM - 3:30 PM
Location:Orange County Convention Center, Hall A2
CME/CE Hours:1.5
Presentations:
404-6: A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism: the JUPITER Trial
Sunday, Mar 29, 2009, 2:00 PM - 2:12 PM
Robert J. Glynn, Eleanor Danielson, Francisco AH Fonseca, Jacques Genest, Antonio M. Gotto, Jr., John JP Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. MacFadyen, Borge G. Nordestgaard, James Shepherd, James T. Willerson, Paul M. Ridker, Brigham & Women's Hospital, Boston, MA
404-8: Eprotirome as a Novel and Physiological Approach to CVD Risk Reduction: Beneficial Effects on Lipoprotein Levels When Added to Statin Therapy
Sunday, Mar 29, 2009, 2:17 PM - 2:29 PM
Jens Kristensen, Bo Angelin, Paul W. Ladenson, E.Chester Ridgway, Irwin Klein, John D. Baxter, Anders G. Olsson, Bo Carlsson, Karolinska University Hospital and Institute, Stockholm, Sweden, Johns Hopkins Medical Institutions, Baltimore, MD
404-10: Signs of Subclinical Coronary Atherosclerosis Measured as Coronary Artery Calcification Improve Risk Prediction of Hard Events Beyond Traditional Risk Factors in an Unselected General Population - The Heinz Nixdorf Recall Study Five-Year Outcome Data
Sunday, Mar 29, 2009, 2:34 PM - 2:46 PM
Raimund A. Erbel, Stefan Möhlenkamp, Susanne Moebus, Axel Schmermund, Nils Lehmann, Nico Dragano, Andreas Stang, Dietrich HW Grönemeyer, Rainer Seibel, Hagen Kälsch, Martina Bröcker-Preuss, Klaus Mann, Johannes Siegrist, Karl-Heinz Jöckel, University Clinic Duisburg-Essen, Essen, Germany
404-12: Treatment of Intermittent Claudication with Hypoxia-Inducible Factor-1α
Sunday, Mar 29, 2009, 2:51 PM - 3:03 PM
Mark A. Creager, Jeffrey W. Olin, Jill Belch, Moneta Gregory, Timothy D. Henry, Sanjay Rajagopalan, Brian H. Annex, Nicholas Chronos, William R. Hiatt, on behalf of Walk Investigators, Brigham and Women's Hospital, Boston, MA
404-14: Multi-center Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria: The ACCF and United HealthCare SPECT Pilot Study
Sunday, Mar 29, 2009, 3:08 PM - 3:20 PM
Robert C. Hendel, Manual D. Cerqueira, Kathleen Hewitt, Karen Caruth, Joseph Allen, Neil Jensen, Michael J. Wolk, Pamela S. Douglas, Ralph D. Brindis, American College of Cardiology Foundation, Washington, DC, United HealthCare, Minneapolis, MN
Session Title:Late-Breaking Clinical Trials III: Emerging Technologies
Session Type:ACC.Special Sessions
Session Start/End Time:Monday, Mar 30, 2009, 8:00 AM - 9:15 AM
Location:Orange County Convention Center, Hall A2
CME/CE Hours:1.5
Presentations:
407-6: The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial
Monday, Mar 30, 2009, 8:00 AM - 8:10 AM
Andrew J. Boyle, Nader Moazami, Ranjit John, Gregory A. Ewald, Analechi C. Anyanwu, Sean P. Pinney, Shashank S. Desai, Nelson A. Burton, Jeffrey J. Teuteberg, Robert L. Kormos, Deborah V. Ascheim, Annetine C. Gelijns, Michael K. Parides, Lyle D. Joyce, The VentrAssist Investigators, University of Minnesota, Minneapolis, MN, Washington University, St. Louis, MO
407-8: First Proof of Long Term Hemodynamic Benefits of Partial Ventricular Support in Patients with Severe Heart Failure
Monday, Mar 30, 2009, 8:15 AM - 8:25 AM
Daniel Burkhoff, Bart Meyns, Stefan Klotz, Andre Simon, Columbia University, New York, NY, University of Leuven, Leuven, Belgium
407-10: BL-1040 Myocardial Implant for the Treatment of Acute Myocardial Infarction
Monday, Mar 30, 2009, 8:30 AM - 8:40 AM
Shmuel Tuvia, Ilan Winkler, Rinat Tabakman, Leah Klapper, Mazal Shaul, Sarit Jencmen, Olga Kaufman, Hanna Ron, Dana Yarden, Moti Gal, Moshe Phillip, Kinneret Savitsky, Jonathan Leor, BiolineRX, Jerusalem, Israel
407-12: Chronic Vagus Nerve Stimulation: a new Treatment Modality for Congestive Heart Failure
Monday, Mar 30, 2009, 8:45 AM - 8:55 AM
Gaetano Maria De Ferrari, Antonio Sanzo, Harry JGM Crijns, Robert Dennert, Goran Milasinovic, Srdjan Raspopovic, Martin Borggrefe, Christian Wolpert, Juergen Kuschyk, Antonina Schoene, Helmut Klein, Jan Smid, Antonello Gavazzi, Markus Zabel, Peter J. Schwartz, Dept of Cardiology, IRCCS Policlinico San Matteo, Pavia, Italy
407-14: Chronic Treatment of Resistant Hypertension with an Implantable Device: Interim 2 Year Results of Two Studies of the Rheos® Hypertension System.
Monday, Mar 30, 2009, 9:00 AM - 9:10 AM
Marcos Rothstein, Peter de Leeuw, Myriah Elletson, for the DEBuT and Rheos Feasibility Investigators, Washington University School of Medicine, St Louis, MO, Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands
407-16: Catheter-Based Renal Denervation Reduces Blood Pressure in Patients With Resistant Hypertension
Monday, Mar 30, 2009, 9:15 AM - 9:25 AM
Henry Krum, Markus Schlaich, Paul Sobotka, Rob Whitbourn, Jerzy Sadowski, Krzysztof Bartus, Boguslaw Kapelak, Wojciech Zajdel, Jacek Godlewski, Horst Sievert, Anthony Walton, Suku Thambar, Murray Esler, Monash University, Melbourne, Australia, Baker IDI Heart & Diabetes Institute, Melbourne, Australia
Session Title:i2.Late Breaking Clinical Trials III
Session Type:i2.Plenary
Session Start/End Time:Monday, Mar 30, 2009, 8:00 AM - 9:30 AM
Location:Orange County Convention Center, Valencia Ballroom W415
Presentations:
Novel Aapproaches for Preventing or Limiting Events (NAPLES) II Trial: Impact of Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
Monday, Mar 30, 2009, 8:00 AM - 8:12 AM
Carlo Briguori, Gabriella Visconti, Amelia Focaccio, Bruno Golia, Matteo Montorfano, Alaide Chieffo, Alfredo Castelli, Bruno Ricciardelli, Antonio Colombo, Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy, Laboratory of Interventional Cardiology, San Raffaele Hospital, Milan, Italy
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention. Preliminary Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Randomized Trial
Monday, Mar 30, 2009, 8:20 AM - 8:32 AM
Germano DiSciascio, Giuseppe Patti, Achille Gaspardone, Vincenzo Pasceri, Giuseppe Colonna, Annunziata Nusca, Rosetta Melfi, Marco Miglionico, Andrea D'Ambrosio, Laura Gatto, Elisabetta Ricottini, Gianluca Pendenza, Antonio Montinaro, Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy
Endovascular versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
Monday, Mar 30, 2009, 8:40 AM - 8:52 AM
Davy Cheng, Dr., Marko Turina, Janet Martin, London Health Sciences Center, London, ON, Canada, University Hospital, Zurich, Switzerland
Immediate Versus Next Day Catheterization in Non-ST Elevation Acute Coronary Syndrome: Results of The Multicenter Randomized ABOARD Study
Monday, Mar 30, 2009, 9:00 AM - 9:12 AM
Gilles Montalescot, Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France
Session Title:Late-Breaking Clinical Trials IV: Acute Myocardial Infarction
Session Type:ACC.Special Sessions
Session Start/End Time:Monday, Mar 30, 2009, 10:30 AM -12:00 PM
Location:Orange County Convention Center, Hall A2
CME/CE Hours:1.5
Presentations:
411-6: Randomized Trial of Omega-3 Fatty Acids on Top of Modern Therapy After Acute Myocardial Infarction: The OMEGA-Trial
Monday, Mar 30, 2009, 10:30 AM -10:42 AM
Jochen Senges, Rudolf Schiele, Steffen Schneider, Helmut Gohlke, Martin Gottwik, Gerhard Steinbeck, Roberto Marchioli, Rudolf Sack, Heinrich Worth, Hugo Katus, Tobias Heer, Reinhilde Zimmer, Werner Richter, Frank Diller, Bernhard Rauch, OMEGA Study Group, Institut fuer Herzinfarktforschung Ludwigshafen an der Universitaet Heidelberg, Ludwigshafen, Germany
411-8: A Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (REVIVAL-3)
Monday, Mar 30, 2009, 10:47 AM -10:59 AM
Ilka Ott, Stefanie Schulz, Julinda Mehilli, Stephanie Fichtner, Martin Hadamitzky, Tarek Ibrahim, Janina Hackl, Katharina Hoppe, Stefan Martinoff, Josef Dirschinger, Adnan Kastrati, Albert Schömig, Deutsches Herzzentrum, Munich, Germany, Klinikum rechts der Isar, Munich, Germany
411-10: Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS)
Monday, Mar 30, 2009, 11:04 AM -11:16 AM
L. Kristin Newby, Robert P. Guigliano, Robert A. Harrington, Paul W. Armstrong, Robert M. Califf, Frans Van de Werf, John Strony, C. Michael Gibson, Gilles Montalescot, Eugene Braunwald, Duke Clinical Research Institute, Durham, NC, TIMI Study Group, Boston, MA
411-12: Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Monday, Mar 30, 2009, 11:21 AM -11:33 AM
Tobias Reichlin, Willibald Hochholzer, Claudia Stelzig, Kirsten Laule, Mihael Potocki, Kathrin Winkler, Stefano Bassetti, Stefan Steuer, Markus Noveanu, Tobias Breidthardt, Nils G. Morgenthaler, Andreas Bergmann, Michael Christ, Christian Mueller, University Hospital Basel, Department of Internal Medicine, Basel, Switzerland
411-14: Influence of 9p21.3 Genetic Variants on Clinical Outcomes in Early-onset Myocardial Infarction
Monday, Mar 30, 2009, 11:38 AM -11:50 AM
Diego Ardissino, Carlo Berzuini, Piera Angelica Merlini, Pier Mannuccio Mannucci, Aarti Surti, Noel Burtt, Benjamin Voight, Marco Tubaro, Flora Peyvandi, Marta Spreafico, Patrizia Celli, Daniela Lina, Maria Francesca Notarangelo, Maurizio Ferrario, Raffaela Fetiveau, Giorgio Casari, Michele Galli, Flavio Ribichini, Marco Rossi, Francesco Bernardi, Nicola Marziliano, Pietro Zonzin, Francesco Mauri, Alberto Piazza, Luisa Foco, Luisa Bernardinelli, David Altshuler, Sekar Kathiresan, Italian Atherosclerosis, Thrombosis, and Vascular Biology Study Group, Pavia, Italy
Session Title:Late-Breaking Clinical Trials V: Lipids and Hypertension
Session Type:ACC.Special Sessions
Session Start/End Time:Monday, Mar 30, 2009, 2:00 PM - 3:30 PM
Location:Orange County Convention Center, Hall WF1
CME/CE Hours:1.5
Presentations:
413-6: Dual Treatment Targets for LDL Cholesterol and C-Reactive Protein After Initiation of Rosuvastatin Therapy: The JUPITER Trial
Monday, Mar 30, 2009, 2:00 PM - 2:12 PM
Paul M. Ridker, Eleanor Danielson, Francisco Fonseca, Jacques Genest, Antonio Gotto, Jr., John Kastelein, Wolfgang Koenig, Peter Libby, Alberto Lorenzatti, Jean MacFadyen, Borge Nordestgaard, James Shepherd, James Willerson, Robert Glynn, for the JUPITER Trial Study Group, Brigham and Women's Hospital, Boston, MA
413-8: Continuous Internet Self Reporting vs. Office Monitoring of Blood Pressure for Reducing Cardiovascular Disease Risk
Monday, Mar 30, 2009, 2:17 PM - 2:29 PM
Alfred Bove, William P. Santamore, Carol J. Homko, Mohammed A. Kashem, Robert C. Cross, Timothy McConnell, Gail Shirk, Francis Menapace, Temple University, Philadelphia, PA, Geisinger Medical Center, Danville, PA
413-10: The ENCORE Study: Examination of Cardiovascular, Metabolic, and Autonomic Changes Associated with the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Hypertensive Men and Women
Monday, Mar 30, 2009, 2:34 PM - 2:46 PM
James A. Blumenthal, Andrew Sherwood, Michael A. Babyak, Lana Watkins, Pao H. Lin, Robert Waugh, Eugene Oddone, Mark Feinglos, Julie Johnson, Carla Caccia, Linda Craighead, Alan Hinderliter, Duke University, Durham, NC, University of North Carolina, Chapel Hill, NC
413-12: Effect of Rosuvastatin Versus Placebo on Cardiovascular Outcomes in Patients with End-Stage Renal Disease on Hemodialysis - Results of the AURORA Study
Monday, Mar 30, 2009, 2:51 PM - 3:03 PM
Bengt Fellstrom, Alan G. Jardine, Hallvard Holdaas, Roland Schmieder, Mattis Gottlow, Eva Johnsson, Faiez Zannad, University Hospital, Uppsala, Sweden, University of Glasgow, Glasgow, United Kingdom
413-14: Impact of Combinations of Three Blood Pressure Lowering Drugs, A Statin and Aspirin on Cardiovascular Risk Factors in 2000 Individuals Without Cardiovascular Disease
Monday, Mar 30, 2009, 3:08 PM - 3:20 PM
Salim Yusuf, Prem Pais, The Indian Polycap Study (TIPS) investigators, McMaster University, Hamilton, ON, Canada, St. John's National Academy of Health Sciences, Bangalore, India
Session Title:Late-Breaking Clinical Trials VI: Arrhythmias/CHF
Session Type:ACC.Special Sessions
Session Start/End Time:Tuesday, Mar 31, 2009, 10:30 AM -12:00 PM
Location:Orange County Convention Center, Hall A2
CME/CE Hours:1.5
Presentations:
416-6: Clopidogrel plus Aspirin versus Aspirin Alone for Prevention of Vascular Events in Patients with Atrial Fibrillation at High Risk of Stroke: The Results of ACTIVE A
Tuesday, Mar 31, 2009, 10:30 AM -10:42 AM
Stuart J. Connolly, Marc Pfeffer, Stefan Hohnloser, Janice Pogue, Cambell Joyner, Robert Hart, John Camm, Salim Yusuf, McMaster University, Hamilton, ON, Canada
416-8: A Randomised Study of The Effects of Optimal Medical Therapy Alone or in Combination With Cardioverter - Defibrillator Implantation on Survival in Patients Early After Myocardial Infarction.
Tuesday, Mar 31, 2009, 10:47 AM -10:59 AM
Gerhard Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann, D. Wojciechowski, Z. Kornacewicz-Jach, M. Zembala, G. Lupkovics, F. Hofgärtner, A. Lubinski, K. Wegscheider, M. Rosenqvist, F. Habets, J. Senges, Ludwig-Maximilians-University, Munich, Germany
416-10: Cardiac Resynchronisation Therapy Prevents Disease Progression in NYHA Class I-II Heart Failure Patients: 24 Months Results from the European Cohort of the REVERSE Trial
Tuesday, Mar 31, 2009, 11:04 AM -11:16 AM
Jean-Claude Daubert, Michael R. Gold, William T. Abraham, Cecilia Linde, Centre Hospitalier Universitaire, Rennes, France
416-12: Prognostic Significance of 123I-mIBG Myocardial Scintigraphy in Heart Failure Patients: Results From the Prospective Multicenter International ADMIRE-HF Trial